$44.88
2.07% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
GB00BYMT0J19
Symbol
LIVN

Livanova PLC Stock price

$44.88
+10.27 29.67% 1M
-5.17 10.33% 6M
-1.43 3.09% YTD
-16.40 26.76% 1Y
-19.99 30.82% 3Y
-7.39 14.14% 5Y
-16.94 27.40% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.91 2.07%
ISIN
GB00BYMT0J19
Symbol
LIVN
Sector

Key metrics

Market capitalization $2.45b
Enterprise Value $2.39b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 16.40
EV/Sales (TTM) EV/Sales 1.87
P/S ratio (TTM) P/S ratio 1.92
P/B ratio (TTM) P/B ratio 2.37
Revenue growth (TTM) Revenue growth 7.97%
Revenue (TTM) Revenue $1.28b
EBIT (operating result TTM) EBIT $-182.46m
Free Cash Flow (TTM) Free Cash Flow $145.52m
Cash position $738.44m
EPS (TTM) EPS $-4.09
P/E forward negative
P/S forward 1.84
EV/Sales forward 1.80
Short interest 3.82%
Show more

Is Livanova PLC a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Livanova PLC Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Livanova PLC forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a Livanova PLC forecast:

Buy
90%
Hold
10%

Financial data from Livanova PLC

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,275 1,275
8% 8%
100%
- Direct Costs 390 390
6% 6%
31%
886 886
9% 9%
69%
- Selling and Administrative Expenses 841 841
80% 80%
66%
- Research and Development Expense 175 175
7% 7%
14%
-130 -130
171% 171%
-10%
- Depreciation and Amortization 53 53
11% 11%
4%
EBIT (Operating Income) EBIT -182 -182
249% 249%
-14%
Net Profit -222 -222
598% 598%
-17%

In millions USD.

Don't miss a Thing! We will send you all news about Livanova PLC directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Livanova PLC Stock News

Neutral
Business Wire
6 days ago
LONDON--(BUSINESS WIRE)-- #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York. The presentation will take place Thurs., June 5, at 3:10 p.m. Eastern Time. The discussion will be available to all interested parties...
Neutral
Seeking Alpha
10 days ago
LivaNova PLC (NASDAQ:LIVN ) Q1 2025 Earnings Conference Call May 7, 2025 8:00 AM ET Company Participants Briana Gotlin – Vice President, Investor Relations Vladimir Makatsaria – Chief Executive Officer Ahmet Tezel – Chief Innovation Officer Alex Shvartsburg – Chief Financial Officer Stephanie Bolton – President, Global Epilepsy Conference Call Participants Rick Wise – Stifel David Roman – Goldm...
Neutral
Business Wire
14 days ago
LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the first quarter ended March 31, 2025 and updated full-year 2025 guidance. Financial Summary and Highlights(1) First-quarter revenue of $316.9 million increased 7.4% on a reported basis, 8.9% on a constant-currency basis, and 10.4% on an organic basis ...
More Livanova PLC News

Company Profile

LivaNova Plc is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the following segments: Cardiovascular and Neuromodulation. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and advanced circulatory support products. The Neuromodulation segment designs and markets NM-based medical devices for the treatment of epilepsy, depression, and obstructive sleep apnea. The company was founded on February 20, 2015 and is headquartered in London, the United Kingdom.

Head office United Kingdom
CEO Vladimir Makatsaria
Employees 2,900
Founded 1987
Website www.livanova.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today